Global Live Stock Vaccine Industry

The Global Live Stock Vaccine Industry is on track for a significant upswing, fueled by the growing importance of animal health and disease prevention. According to a recent analysis, the market is projected to experience a stellar Compound Annual Growth Rate (CAGR) of 6.2% from 2024 to 2034. This translates to a projected market valuation of US$11.2 billion by 2034, reflecting a substantial increase from the US$6.1 billion valuation anticipated for 2024.